» Articles » PMID: 37721699

Changes in the Vaginal Microbiome During Pregnancy and the Postpartum Period in South African Women: a Longitudinal Study

Overview
Journal Reprod Sci
Publisher Springer
Date 2023 Sep 18
PMID 37721699
Authors
Affiliations
Soon will be listed here.
Abstract

Pregnant women in sub-Saharan Africa have high rates of maternal morbidity. There is interest in the impact of the vaginal microbiome on maternal health, including HIV and sexually transmitted infection (STI) acquisition. We characterized the vaginal microbiota of South African women ≥ 18 years with and without HIV in a longitudinal cohort over two visits during pregnancy and one visit postpartum. At each visit, we obtained HIV testing and self-collected vaginal swabs for point-of-care testing for STIs and microbiota sequencing. We categorized microbial communities and evaluated changes over pregnancy and associations with HIV status and STI diagnosis. Across 242 women (mean age 29, 44% living with HIV, 33% diagnosed with STIs), we identified four main community state types (CSTs): two lactobacillus-dominant CSTs (dominated by Lactobacillus crispatus and Lactobacillus iners respectively) and two diverse, non-lactobacillus-dominant CSTs (one dominated by Gardnerella vaginalis and one by diverse facultative anaerobes). From the first antenatal visit to the third trimester (24-36 weeks gestation), 60% of women in the Gardnerella-dominant CST shifted to lactobacillus-dominant CSTs. From the third trimester to postpartum (mean 17 days post-delivery), 80% of women in lactobacillus-dominant CSTs shifted to non-lactobacillus-dominant CSTs with a large proportion in the facultative anaerobe-dominant CST. Microbial composition differed by STI diagnosis (PERMANOVA R = 0.002, p = 0.004), and women diagnosed with an STI were more likely to be categorized as L. iners-dominant or Gardnerella-dominant CSTs. Overall, we found a shift toward lactobacillus dominance during pregnancy and the emergence of a distinct, highly diverse anaerobe-dominant microbiota profile in the postpartum period.

Citing Articles

Exploring the composition of placental microbiome and its potential origin in preterm birth.

Saadaoui M, Djekidel M, Murugesan S, Kumar M, Elhag D, Singh P Front Cell Infect Microbiol. 2025; 14:1486409.

PMID: 39885963 PMC: 11779731. DOI: 10.3389/fcimb.2024.1486409.


Vaginal Microbiome: Environmental, Biological, and Racial Influences on Gynecological Health Across the Lifespan.

Dube-Zinatelli E, Cappelletti L, Ismail N Am J Reprod Immunol. 2024; 92(6):e70026.

PMID: 39670915 PMC: 11640209. DOI: 10.1111/aji.70026.


Gestational diabetes augments group B Streptococcus infection by disrupting maternal immunity and the vaginal microbiota.

Mercado-Evans V, Mejia M, Zulk J, Ottinger S, Hameed Z, Serchejian C Nat Commun. 2024; 15(1):1035.

PMID: 38310089 PMC: 10838280. DOI: 10.1038/s41467-024-45336-6.

References
1.
Nyemba D, Medina-Marino A, Peters R, Klausner J, Ngwepe P, Myer L . Prevalence, incidence and associated risk factors of STIs during pregnancy in South Africa. Sex Transm Infect. 2020; 97(5):375-381. PMC: 8012394. DOI: 10.1136/sextrans-2020-054631. View

2.
Virtanen S, Rantsi T, Virtanen A, Kervinen K, Nieminen P, Kalliala I . Vaginal Microbiota Composition Correlates Between Pap Smear Microscopy and Next Generation Sequencing and Associates to Socioeconomic Status. Sci Rep. 2019; 9(1):7750. PMC: 6533281. DOI: 10.1038/s41598-019-44157-8. View

3.
Ravel J, Gajer P, Abdo Z, Schneider G, Koenig S, McCulle S . Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A. 2010; 108 Suppl 1:4680-7. PMC: 3063603. DOI: 10.1073/pnas.1002611107. View

4.
McClelland R, Lingappa J, Srinivasan S, Kinuthia J, John-Stewart G, Jaoko W . Evaluation of the association between the concentrations of key vaginal bacteria and the increased risk of HIV acquisition in African women from five cohorts: a nested case-control study. Lancet Infect Dis. 2018; 18(5):554-564. PMC: 6445552. DOI: 10.1016/S1473-3099(18)30058-6. View

5.
Anahtar M, Byrne E, Doherty K, Bowman B, Yamamoto H, Soumillon M . Cervicovaginal bacteria are a major modulator of host inflammatory responses in the female genital tract. Immunity. 2015; 42(5):965-76. PMC: 4461369. DOI: 10.1016/j.immuni.2015.04.019. View